Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older

This study has been completed.

Study NCT00048503 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: November 1, 2002 Last Updated: November 20, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2005
Estimated Primary Completion Date:	No date given